Nanotechnology enables the design of targeted drug delivery systems that can deliver antiviral agents directly to infected cells, minimizing side effects and enhancing therapeutic efficacy. For instance, nanocarriers such as liposomes and polymeric nanoparticles can be functionalized with ligands that specifically bind to the spike protein, ensuring that the therapeutic agents are delivered precisely where they are needed.
